Russia to introduce single-dose Sputnik vaccine shot in India

  • Moscow has plans to introduce the single-dose Sputnik Light vaccine in India soon.
  • Sputnik Light vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology.

SPUTNIK LIGHT V. SPUTNIK V

  • Sputnik Light is the first component of Sputnik V – this means it is the first dose of the Sputnik V vaccine. 
  • The vaccine is based on recombinant human adenovirus serotype number 26 (rAd26). 
  • The single-dose Sputnik Light vaccine demonstrated 79.4 percent efficacy, according to analysed data taken from 28 days after the injection was administered as part of Russia’s mass vaccination programme between 5 December 2020 and 15 April 2021.

SPUTNIK V

  • Sputnik V made waves for being the world’s first registered vaccine against coronavirus on 11 August 2020. 
  • Russia's COVID-19 Vaccine Sputnik V is developed by the Gamaleya National Research Institute of Epidemiology and Microbiology. 
  • The vaccine is based on the established human adenoviral vector platform. 
  • The Lancet found Sputnik V to be 91.6 percent effective.
  • The Oxford-AstraZeneca vaccine, being manufactured by Serum Institute of India (SII) here as ‘Covishield’, is also a viral vector vaccine. 
  • Bharat Biotech's Covaxin (BBV152) is an inactivated COVID-19 vaccine.

Comments

Popular posts from this blog

Hamas V. PLO

G7 global corporate Tax Deal

The statue of Swami Vivekananda at the JNU campus